The fibrinolytic system in arteriosclerosis.
D000367:Age Factors; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D001777:Blood Coagulation; D048909:Diabetes Complications; D004032:Diet; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D009765:Obesity / Q000503:physiopathology; D005082:Physical Exertion; D012737:Sex Factors; D012907:Smoking; D013315:Stress, Psychological / Q000503:physiopathology; D013923:Thromboembolism / Q000188:drug therapy; D013927:Thrombosis / Q000150:complications; D013959:Thyroid Diseases / Q000150:complications; D014815:Vitamins / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D007004:Hypoglycemic Agents; D008055:Lipids; D014815:Vitamins